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Adherence of macrophages (MC) to isolated glomeruli (IG): Role of
arachidonic acid metabolites, prostaglandins (PGs) and hydroxyeicosate-
trenoic acids (HETE5). L. Baud, F. Balavoine, J. Sraer, J. Hagege, F.
Delarue, andJ. D. Sraer. Hôpital Tenon, Paris, France. In experimen-
tal glornerulonephritis induced by an injection of glomerular basement
membrane (GBM) antiserum, the accumulation and proliferation of MC
in Bowman's space are thought to play an important role in the
pathogenesis of glomerular injury. We developed a new technique to
determine the number of MC fixed "in vitro" to epithelial cells of IG or
to stripped GBM and examined the role of arachidonic acid metabolites
in this process. Decapsulated IG from rat renal cortex were incubated
with peritoneal MC previously labelled with (5, 6-3H) uridine, and
adherent MC were separated from free MC by filtration. Under these
conditions, MC attached to the epithelial surface of GBM as seen by
transmission microscopy. The level of radioactivity associated with IG
depends on the glomenilar protein and MC concentrations, tempera-
ture, time of incubation, and is a saturable process. MC adherence does
not depend on glomerular cyclooxygenase activity since preincubation
of GI with indomethacin 104M does not modify it. But MC adherence
is partially dependent on glomerular HETEs since preincubation of IG
with nordihydroguiaretic acid 104M, a specific inhibitor of lipoxygen-
ase activity, inhibits this phenomenon by 50%. These results suggest
that the extracapillary accumulation of MC could be promoted in part
by HETEs of glomerular origin.
Hemodialysis biocompatability: Evaluation of dialysate and membranes
respective blood interactions. B. Bran ger, R. Oules, C. Granolleras, G.
Deschodt, D. Treissede, S. Shaldon, and H. Mion. Nephrology-
Biochemistry Department, C.H.R.U., NImes, France. The study was
performed on 11 endstage renal failure patients undergoing maintenance
hemodialysis (HD) for more than I year. Protocol included leukocyte
count (LK), platelet count, CH50, C3, C4 complement fractions, blood
gas measurement every 0.25 hr for 30 mm during recirculating time,
then with the same frequency during the first HD hour, then hourly. In
group I, six patients were dialyzed with cellulose acetate membranes;
in group 2, five patients were dialyzed with cuprophane membranes;
five acetate HD (HDA) were performed before five comparative
bicarbonate HD (HDB). During the late procedure, polyurethane
extruded PVC blood lines were used. The serum prostaglandin level
was measured by RIA before and after HD. Results were corrected for
blood concentration during HD. Profound leukopenia (—55%) occurs
within the first 15 mm, more intense in group 2 (—71.8%) compared to
group 1 (—31.9%) (P < 0.05), associated with CH50 (—17.9%), C3
(—8.1%) fall before C4 fall (—5.3%) later (30 mm). LK and platelets rise
more in HDB (+ 18.7%, +27.3%) compared to HDA (+4.9%, +9.6%)
(P < 0.05). The rise of TxB2 is greater in HDA (+ 293%) compared to
HDB (+ 193%) (P < 0.05). In conclusion, (I) our results suggest that
alternative complement activation pathway initiates leukocyte count
drop and does not modify Pa02 and PaCO2; (2) leukopenia is more
intense in group 2 compared to group I, with the same complement
activation; (3) these phenomena are slowly corrected during HD
procedure, with a greater rise in leukocytes and platelets with HDB
compared to HDA; (4) thromboxane activation is more intense in HDA
compared to HDB.
In vitro studies of the regulation of anti.GBM autoantibody synthesis in
the Brown-Norway rat. J. M. Chalopin, D. K. Peters, and C. M.
Lockwood. Department of Nephrology and Transplant immunology,
Hôpital du Bocage, Dijon, France, and Department of Medicine, Royal
Postgraduate Medical School, Hammersmith Hospital, London, Unit-
ed Kingdom. The kinetics of the plaque-forming responses to glomeru-
lar basement membrane (GBM)-coated erythrocytes were examined
during the course of an experimental autoimmune nephritis induced by
mercuric chloride (HgCI2) in the Brown-Norway rat. A positive direct
response (>2 DS response of normal spleen cells) occurred as early as
day 4 and was maximal at days 9 and 10 [up 3, 4 x l0 GBM specific
plaque-forming cells (PFC) spleen]. Spontaneous arrest of GBM-PFC
formation occurred after day 10. The addition of soluble GBM to the
plaquing mixture inhibited GBM specific PFC in a dose-dependent
fashion in animals up to day 10 but, surprisingly, in certain animals
sacrificed after day 10 the response was increased by additional GBM.
Other investigators showed that similar antigen enhancement of the
PFC response was due to displacement of an autoanti-idiotype antibody
in a study of PFC responses to TNP-ficoll in the AKR/J mouse. In
further studies sera from animals giving augmentable PFC responses
could inhibit specific GBM-PFC responses when added to the plaquing
mixture. This autoimmune nephritis model may allow further studies of
mechanism by which auto-antibody can be controlled by serum factor
(putative autoanti-idiotype). Such studies carry important implications
for management of human autoantibody-mediated diseases.
Acute renal failure (ARP) due to megalocytic interstitial nephritis
(MIN). Improvement with corticosteroid therapy. J. Cledes, J. P. Herve,
J. P. Leroy, and V. Plais. Department of Nephrology and Pathology,
C.H.U. Brest, France. A 68-year-old woman with hypertension but
without other medical antecedents presented with rapidly progressive
oliguric and febrile renal failure (serum creatinine = 600 smoles/titer).
Urinary cytology revealed hematuria and leucocyturia. A severe in-
flammatory syndrome existed but blood cultures were sterile. Radiolog-
ically, kidneys are regular and enlarged. Microscopically, the renal
cortex showed an intense polymorphic interstitial infiltrate with a
predominance of histiocytes; the medulla was spared. In the cells, PAS
positive granules were numerous but Michaelis-Gutmann (MG) bodies
were absent. By electron microscopy, histiocytes were shown to
contain numerous phagolysosomes and lipidic droplets and a single
crystalloid electron-lucent rod-shaped body. The function of the poly-
morphonuclear leucocytes were studied and a transitory and isolated
defect in killing Staphylococcus aureus in autologous (61% N = 97%)
and homologous serum (49% N = 80%) was demonstrated. Corticoste-
roid and antibiotic therapy was instituted and diuresis immediately
resumed. One year later, the kidneys exhibited a normal radiological
appearance; proteinuria (0.45 glday), hematuria, and moderate renal
insufficiency (Ccr = 43 mI/mn) persist. The absence of MG bodies and
lack of involvement of medulla differentiate this MIN patient from renal
malacoplakia. From this case report, we stress the following points: (I)
infection or metabolic abnormalities are not necessary; (2) MIN is
rarely bilateral and then associated with ARF; (3) electron-lucent rod-
shaped crystalloid bodies may be very rare; (4) a killing defect of
polynuclear cells is evidenced; (5) medical treatment can improve the
outcome.
Studies on blood and peritoneal dialysate levels of Cefoperazone in
patients on continuous ambulatory peritoneal dialysis. S. Dalac, J. F.
Cabanne, A. Kazmierczak, A. Pechinot, E. Solarv, Y. Tanter, and G.
Rifle. Service de Nephrologie et Laboratoire de Bactériologie, Centre
Hospitalier Universitaire, Dijon, France. Blood and peritoneal dialy-
sate (PD) levels of Cefoperazone (CFP) were determined in 12 patients
on continuous ambulatory peritoneal dialysis (CAPD) presenting or not
with peritonitis, after intraperitoneal (i.p.) or intravenous (i.v.) adminis-
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tration of this new cephalosporin. CFP was selected because of its wide
bacterial spectrum and its low renal elimination. CFP concentrations
were determined both by HPLC and microbiological method. The
CAPD is performed by four exchanges from 1.5 to 2 liters a day (at 4, 8,
12, and 24 hr) and by 12 exchanges a day (every 2 hr) in case of
peritonitis. Three protocols (01, G2, G3) were studied in three groups
of four patients: G I, i.v. administration of 2 g CFP by 30-mm infusion at
TO and T12; G2 and G3, i.p. administration of 200 ig/ml CFP on every
exchange. 03 patients presented a proven bacterial peritonitis. In 01,
the range half-life of CFP in blood was 2.06 to 2.9 hr after the first
infusion and 2.01 to 2.77 hr after the second. The range of PD levels was
7.75 to 20.8 gJml, 4 hr after the first infusion. In G2, the serum level of
CFP reached a plateau at the sixth hour, ranging from 8.19 to 22.25 ag/
ml. On the other hand, in 03, the serum level of CFP reached a plateau
between hours 14 and 16, with higher rates (m = 50 sg/ml). Peritonitis
was cured in the four patients as early as hour 12. This study showed
the transperitoneal passage of CFP even without peritonitis. The blood
levels obtained after i.p. administration were sufficient to treat a
possible bacterial dissemination because of usual minimal inhibitory
concentration of CFP. PD levels obtained after i.v. administration
suggested that the utilization of this route was possible for treating
peritonitis (further studies: group 4).
Fabry's disease discovered by isolated nephrologic symptoms (two
observations). J. P. Herve, J. Cledes, B. Garo, M. P. Ramee, D.
Chevet, and J. P. Leroy. Service de Néphrologie, Service d'Anatomo-
Pathologie, C.H.R. Morvan, Brest, and Unite de Nephrologie, Service
d'Anatomo-Pathologie, C.H.R. Pontchaillou, Rennes, France. A 33-
year-old male was admitted with chronic proteinuria in 1973 without
any clinical or biological symptom favoring a systemic disease. A
kidney biopsy revealed glomerular spumous cells. Diagnosis of Fabry
disease was confirmed by abnormal excretion of glycosphingolipids and
by the absence of leukocytic alpha-galactosidasic activity. A corneal
dystrophy was discovered. The evolution toward renal insufficiency
required hemodialysis 5 years later. The patient was transplanted
successfully 8 months later. His 56-year-old maternal uncle had chronic
renal insufficiency (Ce. 40 mI/mm) with proteinuria and hypertension.
No biological or clinical symptom except coronary insufficiency was
indicative of Fabry disease. The light and electronic microscopy
examination of the kidney biopsy specimen demonstrated characteristic
lesions. Later, diplopia and vertigo appeared. Genetic investigation of
the first patient's two daughters demonstrated a decrease of intraleuko-
cytic-alpha-galactosidasic activity. The corneal dystrophy, a link be-
tween the Fabry gene and Xg erythrocytic group were confirmed.
These two patients should be added to the seven former observations in
which nephrologic symptoms revealed the specific biochemical abnor-
mality of Fabry disease. These minimal forms share the unfavorable
nephrologic outcome of the disease.
Protein malnutrition in hemodialysis patients (HD). Critical study of
anthropometric and biologic criteria. Involvement in the immune deficit.
J. P. Herve, J. Cledes, P. Miossec, B. Garo, J. Jouquan, and P.
Youinou. Service de Néphrologie, Unite d'lmmunologie, et Service de
Médecine Interne Vaquez; et C.H.U. Brest, France. Protein malnutri-
tion (PM) in HD patients is underestimated because of the difficulty of
its interpretation in these patients. We wanted to stress the importance
of PM with regard to immune deficiency. Forty-six HD patients (sex
ratio 1:2, mean age = 49 years) without recent complications were
studied. CRF duration = 52 months 35, HD duration = 35 months
37, 1 g/kg protein intake, 2200 cal. Dry weight, triceps skinfolds, arm
muscle circumference (AMC) were assessed and compared with
matched controls. Because AMC is a good criterium for estimating
protein mass, we defined clinical protein malnutrition when its value
was under mean 2 SD of controls. Biological criteria: albumin (Biuret
and electrophoresis methods), pre-albumin, transferrin, and retinol-
binding protein (according to Mancini) were determined. Cellular
immunity was assessed on the total lymphocyte count, E-Rosette
forming cells (JF Bach), and E active RFC (Wybran and Fundenberg).
Clinical protein malnutrition was found in 24 patients. We found no
statistical correlation between AMC values and protein levels. In
patients with protein malnutrition T lymphocyte subsets were de-
pressed significantly.





Total Ly Count 1.375 437 1712 414 P < 0.001
E RFC 1.069 376 1349 391 P < 0.002
E Active RFC 554 285 721 220 P < 0.005
In conclusion, we found: first, that protein criteria fail to assess protein
malnutrition in CRF; second, that protein malnutrition is important in
the immune deficiency found in HD.
Frequent association of scleritis and IgA nephropathy or glomerulone-
phritis with mesangial C3 deposits. B. Hurault de Ligny, D. Sirbat, M.
C. Bene, G. Faure, and M. Kessler. Services de Nephrologie et
Ophtalmologie, C.H. U. de Brabois, et Laboratoire d'Immunologie,
Faculté de Médecine, Nancy, France. Sclerites are frequent lesions of
the eye, often associated with systemic diseases, allergy, and infec-
tions. They have previously been observed in six patients with Berger
disease (BD), who were the only patients with this eye lesion among 113
with glomerulonephritis (ON). A similar association was sought in a
series of 53 ON patients and 40 control subjects. The results demon-
strate the absence of scleritis in all controls, in five patients with ON
with minimal lesions, four with focal GN, and in three patients
presenting only with vascular lesions and microscopic hematuria.
Scleritis was found in five out of 27 BD (18%); none of the patients had
anaphylactoid purpura or liver cirrhosis; three out of five patients
exhibited mesangial C3 deposits (75%), one out of two patients had
membranous ON, and one out of five patients had membranoprolifera-
tive GN. None of these patients suffered from any of the other diseases
known to be associated with scleritis. The patients with scleritis had
similar levels of serum IgA as those without scleritis. Fifteen out of 25
BD patients without scleritis (60%) had circulating immune complexes
activating the alternate pathway of complement-circulating immune
complexes activating the alternative pathway of complement, (CICAP)
while four out of the five BD patients with scleritis had CICAP (80%).
One of the patients with C3 mesangial deposits and scleritis had such
dC. Little is known about the pathogenesis of scieritis. These results
suggest that CICAP might play some part in it, eventually leading to the
formation of local deposits on altered tissue.
Ocular disturbances during treatment by fiumequine. B. Hurault de
Ligny, D. Sirbat, M. Kessler, E. Saudax, A. Raspiller, and C. Huriet.
Services de Nephrologie et d'Ophtalmologie, C.H.U. de Brabois,
Nancy, France. Among side effects occurring after qumnolone therapy,
visual disturbances have been reported, but no specific alteration has
described. We observed ocular problems in two kidney transplanted
patients with advanced graft failure receiving corticosteroids and immu-
nosuppressive drugs who were prescribed flumequine as treatment for
urinary infections. Both patients presented with a relative central
bilateral scotoma. Direct ophtalmoscopy and fluorescein angiography
showed a macular symetric bilateral edema related to a serous detach-
ment of the macular epithelium. Ocular disturbances occurred suddenly
in both patients shortly after the beginning offiumequine administration
and were immediately bilateral and symmetric. Visual acuity was only
slightly altered. Rapid and complete recovery occurred within 2 days
after the treatment was stopped, leaving no sequelae. There are many
similarities between these two patients: flumequine was prescribed at
normal doses; associated therapies were identical in these two trans-
planted patients. There were signs of kidney failure with renal clearance
at 20 mI/mm. The pharmacokinetic study of fiumequine shows that
serum peaks are higher in renal failure patients. It therefore seems
advisable to exercise care in prescribing this drug for patients with
chronic renal failure, that is, with renal clearance lower than 30 mI/mm.
The possible role of associated treatments, although difficult to assess,
might also be important; both patients were receiving similar treatment.
Complementary pharmacokinetic studies will help elucidate the mecha-
nisms of such deleterious side effects.
Aluminum in the joint tissues of chronic renal failure patients treated
with regular hemodialysis and aluminum compounds. M. Kessler, P.
Netter, D. Burnel, M. F. Hutin, S. Delons, B. Hurault de Lign%', C.
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Huriet, andA. Gaucher. C.H.U. deBrabois, Nancy, France. Hypothe-
sizing that aluminum salts were toxic to bones and joints, we studied the
concentrations of aluminum in the articular tissue samples of five
hemodialyzed patients treated with aluminum compounds. We found
that aluminum crosses the synovial barrier, is found in synovial fluid,
and accumulates in the joint structures (synovial membrane and joint
cartilage). The concentrations in synovial tissue samples were 2.7 to 10
times, in synovial fluid 2.5 to 8 times, and in cartilage 2.6 times the
respective control concentrations. By electronic microscopy, aluminum
seems to be localized in the lysosomial structures, and the presence in
certain cellular synovial tissue components of aluminum associated
with phosphate was demonstrated definitively by dispersive micro-
probe analysis. The present work demonstrated the accumulation of
aluminum in the articular tissue of renal patients. When articular signs
occur in such patients, the possible responsibility of aluminum may be
considered.
Suppressor cell function in mercuric chloride-induced autoimmune
nephritis in the Brown-Norway rat. C. M. Lockwood, D. W. Mason, and
C. Bowman. Departme,u of Medecine, Royal Postgraduate Medical
School Hammersmith Hospital, London, United Kingdom. Brown-
Norway rats, convalescent after mercuric chloride-induced autoim-
mune nephritis, are resistant to rechallenge with mercuric chloride for a
period of up to 6 months. We have transferred, via tail artery injection,
6 x l0 to 2 x l0 spleen cells from rats convalescent at days 21 to 29 to
naive rats. Significant suppression (P = 0.01) of peak antibody levels
was noted in the naive recipients (N = 24) when compared to animals
receiving medium alone (N = 20). Transfer of equivalent numbers of
normal rat spleen cells does not cause suppression. When T suppressor
(Ts) cells are removed from the convalescent spleen cells before
transfer using a monoclonal antibody to rat Ts cells, the suppression is
abrogated (N = 11, P < 0.002). These findings support a key role for Ts
cells in the regulation of antibody production.
Hemodialysis or transplantation in the treatment of endstage polycystic
kidney disease (ESPK)? Y. Pirson, J. M. Vandenbroucke, J. P. Squifflet,
G. P. J. Alexandre, and C. van Ypersele de Strihou. Université
Catholique de Louvain, Cliniques Universitaires St-Luc, Brussels,
Belgium. Results of renal transplantation (TP) in ESPK have been
reported to be less favorable than in other endstage renal disease,
whereas by contrast, results of hemodialysis (HD) are said to be better.
We have reviewed the evolution of 61 patients with ESPK treated
between 1966 and 1982: Thirty-three received 35 grafts (34 from cadaver
donors and one from a living donor, group TP); the 28 others were
treated solely by HD (group HD). Actuarial patient and graft survival of
group TP (mean age: 41.8 years) at 12 and 36 months is 75.0 and 66.0%,
respectively, and 59.1 and 46.1%; these results are virtually identical to
those of a control group of transplanted patients matched for age, sex,
type of graft, and time of TP. Patient survival is related to the age of the
recipients: 3-year survival is 87.5% in patients 40 years (N = II) vs.
only 54.9% in patients >40 years (N = 22). Patient survival in the group
HD (mean age: 51.0 years) is 100 and 84.2% at 12 and 36 months,
respectively, thus reaching the values obtained in 40 years TP
subgroup. Bi-nephrectomy was performed in only two (7%) patients of
group HD, but in 20(61%) of group TP. Our data suggest that TP is fully
warranted in younger patients with ESPK whereas HD should be
preferred in patients older than 40 years. This conclusion is further
strengthened by the observation that bilateral nephrectomy often
needed in transplanted patients is associated with a significant morbid-
ity and will impair rehabilitation if the patient returns to HD.
Renal toxicity of 9 hydroxy 2 methylellipticinium. J. P. Ryckelynck, P.
Juret, J. F. Heron, E. de Ranieri, P. Herlin, andf. Y. le Talaer. Service
Néphrologie et Médecine Interne, C.H. U. Clémenceau, Caen, Services
de Médecine, d'Anatomopathologie, et de Biochimie, Centre Fran cois
Baclesse, Caen, France. An intercalating antimitotic drug, 9 hydroxy 2
methylellipticinium, is mainly potent in metastatic breast cancer. Be-
cause of low hematological toxicity, ellipticinium is more and more
used in osseous metastates. As many as 385 patients have been treated.
Twenty patients with renal failure were observed, and ten died of their
renal disease. It is gradual and nonreversible despite drug discontinua-
tion, except in four patients with acute renal failure. Histological and
ultrastructural studies showed that only tubular lesions occur with signs
of epithelial regeneration and lamellar basal membranes. One patient
had histological lesions without renal failure. We a study of tubular
toxicity. We observed an increase in urinary protein excretion, 132
microglobulin, N-acetyl-D-glucosaminidase and alanin-aminopeptidase
during drug therapy. Patients who received nephrotoxic drugs seem to
be more sensitive. It is our opinion that renal function should be
carefully followed when patients are treated with ellipticinium.
Renal transplantation and continuous ambulatory peritoneal dialysis:
Evaluation of infectious risk. J. P. Ryckelynck, C. Verger, D. Pierre, J.
C. Sabatier, B. Faller, and J. M. Beaud. Service de Nephrologie et
Médecine Interne, C.H.U. Clemenceau, Caen, C.H.R. Pontoise,
C.H.R. Orleans, C.H.R. St. Etienne, C.H.R. Colmar, et E.C.H.O.
Nantes, France. With the increasing number of young patients treated
by CAPD, the question arises of evaluating the risk of infection related
both to bouts of peritonitis and the presence and use of the catheter
after transplantation. Six centers have transplanted a total of 17 patients
with a mean age of 36.8 years (range, 12.5 to 51 years). Mean duration
of CAPD treatment was 10 months (range, 0.5 to 30 months). Rate of
peritonitis was one episode every 5.3 patient-months. Among the 17
patients, five had no peritonitis and two patients presented a peritonitis
successfully treated less than 10 days before transplantation. Ten out of
17 patients had a functioning graft after 15.2 months (range, I to 43
months). Catheter removal was carried out 0 to 120 days (mean, 50
days). Five patients were maintained on CAPD for 5 to 30 days after
transplantation. No peritonitis occurred. No death related to infectious
diseases was observed. In one patient a tunnel infection was diagnosed
when the catheter was removed and was successfully treated with local
antibiotics. These results suggest that CAPD does not increase the risk
of infection after transplantation. A comparative study with hemodialy-
sis patients is in progress in the same centers.
Isolation of cells from the thick ascending limb of Henle in rats. A.
Tejedor, L. Bankir and L. Eloy. Institut National de Ia Sante et de Ia
Recherche Medicale Unite 90, Hôpital Necker, Paris, France. Cells
from the thick ascending limb of Henle's loop (TAL) are isolated from
an inner stripe cell suspension in the following way: three to four rats
are anesthetized with Nembutal, 50 mg/kg body weight i.p., tracheosto-
mized and infused intravenously for 10 mm with NaCI 0.9%, 1 mI/mm.
Kidneys are perfused in situ through a catheter inserted into the
abdominal aorta. The aorta above the renal arteries is tied, and the vena
cava is opened to ensure drainage. A modified Krebs-Ringer-phos-
phate-bicarbonate solution (KRPB = NaCI 111 mt, KCI 4.7 mM,
SO4Mg 1.2 mi, PO4HNa 10 mri, PO4H2K 1.2 mrt, COHNa 16.6 mM
plus CaCl2 0.125 m, and glucose 5 mi) pH 7.4, osmolality 320 mOsm/
kg H20, saturated with 95% 02 to 5% CO2 (02/C02) is used at an initial
flow rate of 7 mI/mm. After 30 mi KRPB with I mg/mI collagenase
(Worthington type 2) is infused for 10 mm at 2 mI/mm. Kidneys are
excised, the cortex and superficial medulla cut out, and the white inner
medulla excised. The remaining tissue (mostly inner stripe) is minced
and incubated in 10 ml KRPB-collagenase with 02/C02 at 37°C for 45
mm. The resulting suspension is filtered through three successive nylon
sieves 75-, 53-, and 37-sm pore size. The filtrate is centrifugated at
x bOg for 10 mm. The pellet mainly contains cells from TAL, thin-
limbs, and collecting ducts. The TAL cells are easily recognized from
the others by their size and refringence. The pellet is carefully laid on
the top of a preformed 25 to 60% Percoll gradient (Pharmacia), made
isoosmotic by the addition of KRPB. After centrifugation at x400g for
20 mm, five cell layers are observed; the third one contains more than
80% TAL cells excluding Trypan Blue. This technique provides about
20 mg fresh cells from eight rat kidneys and can be completed in 3 hr.
Systemic familial hyalinosis with mesangiolysis: A new syndrome. G.
Touchard, J. C. Rambaud, A. Galian, L. Morel-Maroger, D. Droz, J.
P. Grunfeld, C. Matuchansky, D. Patte, andJ. Payen. C.H.U. Poitiers,
France. We report four patients with systemic vascular hyalinosis (H).
This new syndrome affected three out of seven siblings. The fourth
patient was without known family association. All four patients were
young caucasian females (23 to 40 years old). Clinical symptoms were
nephrologic, or digestive. The three sisters presented a peculiar mor-
photype: They were small and thin with a bird facies." Rachis curves
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were nearly absent. Canitia, poliosis, and telangiectasias were noted in
four patients. Two patients presented some nodular subcutaneous limb
calcifications. The complete syndrome associated cerebral calcifica-
tions, ischemic retinal syndrome, proteinuria and renal failure, diges-
tive symptoms (bleeding, diarrhea with reduced oroanal transit, plasma
protein losses, Bl2 malabsorption) and osseous X-ray abnormalities.
The glycoregulation, phosphocalcic metabolism including PTH and
karyotype were normal. The primary lesion was a severe and progres-
sive H of small vessels affecting predominantly the retina, basal ganglia,
digestive tract, and the kidney. Renal biopsy specimens from all
patients showed an arteriolar and glomerular H with severe mesangioly-
sis similar to that induced by Mitomicyn C or radiations. These
arteriolar and glomerular lesions resulted in sclerosis. In the digestive
tract the H of the mucous capillary wall sometimes coexisted with an
aneurismal dilatation of the capillary lumen. Electron microscopy
showed that H corresponded to a multilayered capillary basement
membrane. In the kidney an abundant clear fluffy material invaded and
mesangial spaces of the glomeruli. Endothelial and mesangial cells were
severely altered. One patient died when she was 28 from massive rectal
bleeding. We suggest that this syndrome is linked to endothelial cell
death or dysfunction of genetic origin or due to an embryofoetopathy.
Production of monoclonal antibodies against rabbit kidney cell popula-
tions. A. Vandewalle, P. Ronco, M. Geniteau, and P. Verroust. Inst it ut
National de Ia Sante et de Ia Recherche Medicale Unite 64, Paris,
France. Considerable efforts have been made to identify the various
biochemical and physiological functions of the cell types constituting
the nephron. Most studies have been performed using microdissection
techniques which allow clear identification of the cell types but provide
small amounts of material. In contrast, large numbers of cells can be
easily isolated, but their identification and subsequent fractionation
remain cumbersome. If available, immunological tools could be of
considerable help. We have therefore undertaken the production of
monoclonal antibodies against specific populations of tubular cells.
Spleen cells from Balb/c mice immunized either with isolated cortical
cells from rabbit kidney or plasma membrane preparations were fused
with the nonsecreting NSI myeloma line. Hybrids selected by conven-
tional methods were tested for antibody production by solid phase
enzymoassay on crude cortical membrane preparations and by indirect
immunofluorescence (IF) on frozen sections of rabbit kidney. Twenty-
two clones were finally kept. Seventeen produced IgG and five 1gM.
Isoelectrofocusing of internally labelled antibody (Ab) confirmed mono-
clonality. Four main groups could be demonstrated by IF on tissue
sections and microdissected isolated tubules. Group I consisted of II
Ab that recognized antigens located on proximal tubule brush borders.
Different IF patterns were obtained suggesting different specificities.
Group 2 consisted of four Ab directed against antigens of the basolateral
membranes present on all tubular segments (3) or only on the proximal
tubule (I). Group 3 consisted of one antibody that recognized only
collecting tubules. Group 4 consisted of six antibodies that bound to
antigens related to the cytoskeleton. These experiments show that
monoclonal antibodies highly specific to rabbit cortical kidney cell
preparations can be obtained. These reagents will be useful for physio-
logical and immunological studies.
Renal radionuclide investigation of urinary tract obstruction: An
experimental study in dogs. B. Wehbe, A. Moisan, D. le Cloirec, N.
Afiouni, F. Saudreau, P. le Pogamp, and D. Chevet. Services des
Nephrologie ef Radioisotopes, C.H. U. Rennes, France. The purpose of
this experiment was to compare several isotopic tracers in renal
investigation in 17 anesthesized dogs at three successive experimental
phases, using the same protocol: (1) as controls; (2) 1 week after partial
ligation of a pelvic ureter; (3) after ligation of the remaining ureter. The
protocol was as follows: study of the mTcDMSA uptake rate in each
kidney, GFR estimation by studying the integral plasma clearance of
1251 isothalamate and the integral and divided 99mTcDTPA plasma
clearance quantified on the basis of scintigraphic data, study of IVPS.
Results showed no modification of either renal morphology or function
prior to surgery in the 17 dogs. In this phase close correlation existed
between the three radiotracers used to measure integral renal function
values: 1251 lothalamate vs. 99Tc-DTPA = 0.90 — 251 lothalamate vs.
Tc-DMSA = 0.88 — ssmTc DTPA vs. 9smTcDMSA = 0.86. After
partial ligation the divided clearance values of mTcDTPA and the
s9mTc..DMSA uptake percentage of each kidney were correlated: a
significant assymetry (P < 0.01) between the healthy and the obstructed
kidney in each dog was found. Modification of the radiotracer disap-
pearance curve on the renogram confirmed the obstruction. Bilateral
ligation caused renal failure in all animals, but the degree varied from
one dog to another. The isotopic tests showed a concordant estimate of
the drop in GFR. These experimental results suggest that technetium-
labelled DTPA is the most efficient radionuclide in urinary tract
obstruction in humans.
